Holen Sie sich die Stockscreener-App
10.94
4.54%
-0.52
Handel nachbörslich:
10.94
Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
32.25%
9.839
|
14.52 | 11.65 | 9.693 | 63.74 |
| Operating Expenses |
10.08%
39.73
|
44.18 | 49.70 | 58.15 | 67.09 |
| Operating Income/Loss |
0.78%
-29.89
|
-29.66 | -38.05 | -48.46 | -3.345 |
| Income/Loss From Continuing Operations Before Tax |
0.09%
-38.53
|
-38.50 | -46.84 | -56.86 | -11.52 |
| Income Tax Expense/Benefit |
106.67%
0.001
|
-0.015 | -0.082 | - | -0.018 |
| Net Income/Loss |
0.13%
-38.53
|
-38.48 | -46.76 | -56.86 | -11.50 |
| Basic Average Shares |
26.67%
16.57
|
13.08 | - | 84.87 | 84.58 |
| Diluted Average Shares |
26.67%
16.57
|
13.08 | - | 84.87 | 84.58 |
| Basic Earnings Per Share |
20.75%
-2.33
|
-2.94 | - | -0.67 | -0.14 |
| Diluted Earnings Per Share |
20.75%
-2.33
|
-2.94 | - | -0.67 | -0.14 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):